Evolutionary Genomics Inc. logo

Evolutionary Genomics Inc. (FNAM)

Market Closed
11 Aug, 20:00
OTCQB OTCQB
$
0. 00
0
0%
$
1.33K Market Cap
- P/E Ratio
- Div Yield
300 Volume
0 Eps
$ 0
Previous Close
Add Transaction
Day Range
0 0
Year Range
0 0
Want to track FNAM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

FNAM closed yesterday higher at $0, an increase of 0% from Monday's close, completing a monthly increase of 0% or $0. Over the past 12 months, FNAM stock gained 0%.
FNAM is not paying dividends to its shareholders.
The last earnings report, released on Sep 12, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Evolutionary Genomics Inc. has completed 1 stock splits, with the recent split occurring on Oct 19, 2015.
The company's stock is traded on one exchange.

FNAM Chart

People also search for

Security Devices International, Inc.
$ 1
-3.8462%
Vivos Inc.
$ 0.05
+4.3893%
Telescope Innovations Corp.
$ 0.31
+0.0318%
Inhibitor Therapeutics Inc.
$ 0.08
0%
Pacific Health Care Organization Inc.
$ 1
0%

Evolutionary Genomics Inc. (FNAM) FAQ

What is the stock price today?

The current price is $0.00.

On which exchange is it traded?

Evolutionary Genomics Inc. is listed on OTCQB.

What is its stock symbol?

The ticker symbol is FNAM.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 1.33K.

Has Evolutionary Genomics Inc. ever had a stock split?

Evolutionary Genomics Inc. had 1 splits and the recent split was on Oct 19, 2015.

Evolutionary Genomics Inc. Profile

Biotechnology Industry
Healthcare Sector
Steven Bryan Warnecke CEO
OTCQB Exchange
30051F101 CUSIP
US Country
2 Employees
- Last Dividend
19 Oct 2015 Last Split
- IPO Date

Overview

Evolutionary Genomics, Inc., situated in Castle Rock, Colorado, operates at the forefront of genetic research with a focus on positively selected genes across humans, animals, and commercial crops. By leveraging its subsidiaries’ capabilities, the company ventures into identifying genes that play key roles in various biological traits and adaptations. This initiative underpins its commitment to service the broad spectrum of clients that include governmental organizations, non-profit foundations, and commercial entities. Through its expansive research and innovative approaches, Evolutionary Genomics strives to uncover the genetic foundations that can be harnessed to address contemporary challenges in agriculture, health, and environmental sustainability.

Products and Services

  • Adapted Traits Platform

    This technological platform represents the company’s core initiative to revolutionize the field of agricultural biotechnology. By identifying genes that contribute to critical agricultural traits such as yield enhancement, sugar content augmentation, increased biomass, improved drought tolerance, and enhanced resistance to pests and diseases, the Adapted Traits Platform paves the way for developing crop plants that are not only more productive but also more resilient to the challenges posed by climate change and environmental degradation. This platform serves as a beacon of hope for increasing food security and sustainability in agricultural practices worldwide.

Contact Information

Address: 4220 Morning Star Drive
Phone: 720 900 8666